ArticlePoultry science2026
Heterologous expression, immunogenic evaluation, and subunit vaccine potential of the σC protein from the Xinjiang avian reovirus (ARV) strain xj-1.1.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avian reovirus (ARV) causes a range of diseases in poultry and results in significant economic losses for the poultry industry. To address the epidemic of ARV infection in yellow-feathered broilers in Xinjiang, this study conducted genetic and evolutionary analyses of a chicken-origin ARV field strain, designated ARV xj-1.1. The σC gene of this strain was expressed in vitro using both Escherichia coli and Pichia pastoris systems to compare expression characteristics and immunogenicity. Phylogenetic analysis revealed that ARV xj-1.1 belongs to genotype IV. The σC gene was successfully cloned and efficiently expressed in both prokaryotic and eukaryotic systems. After purification by nickel affinity chromatography, recombinant proteins pET-σC and GS115/pPIC9K-σC were obtained. Post-translational modification analysis indicated that neither recombinant protein exhibited glycosylation; however, phosphorylation levels differed, with values of 5.9% and 21.7%, respectively. Immunogenicity evaluation showed that both recombinant proteins induced high antibody titers in mice (1:51,200 for pET-σC and 1:102,400 for GS115/pPIC9K-σC). In immunized chicks, antibody levels peaked in the third week post-vaccination, and neutralizing antibody titers were significantly higher than in the control group (P < 0.01). Challenge experiments confirmed that vaccinated chicks exhibited no clinical symptoms or gross lesions, whereas the challenged controls displayed classic signs such as depression, swollen footpads, and visceral hemorrhage. These results demonstrate that the σC protein possesses strong potential as a subunit vaccine antigen. Although the eukaryotically expressed protein exhibited higher phosphorylation, the prokaryotically expressed σC protein induced a stronger neutralizing antibody response. This study provides a theoretical and experimental foundation for the development of regional ARV subunit vaccines and has important implications for controlling ARV infections among poultry in Xinjiang.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.